PortfoliosLab logoPortfoliosLab logo
SMMT vs. VRT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SMMT vs. VRT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Summit Therapeutics Inc. (SMMT) and Vertiv Holdings Co. (VRT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SMMT achieves a -19.33% return, which is significantly lower than VRT's 85.57% return.


SMMT

1D
-4.47%
1M
-21.96%
YTD
-19.33%
6M
-24.24%
1Y
-31.47%
3Y*
100.52%
5Y*
13.84%
10Y*
4.15%

VRT

1D
0.02%
1M
-11.59%
YTD
85.57%
6M
61.97%
1Y
160.87%
3Y*
142.34%
5Y*
62.98%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SMMT vs. VRT - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
SMMT
Summit Therapeutics Inc.
-19.33%-1.99%583.72%-38.59%57.99%-42.77%193.75%39.13%-51.48%
VRT
Vertiv Holdings Co.
85.57%42.80%136.82%251.81%-45.25%33.80%69.36%12.55%1.03%

Correlation

The correlation between SMMT and VRT is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Jul 30, 2018

0.12

Fundamentals

Market Cap

SMMT:

$10.94B

VRT:

$117.86B

EPS

SMMT:

-$1.60

VRT:

$3.99

PB Ratio

SMMT:

20.04

VRT:

27.77

Total Revenue (TTM)

SMMT:

$0.00

VRT:

$10.84B

Gross Profit (TTM)

SMMT:

-$83.36K

VRT:

$3.92B

EBITDA (TTM)

SMMT:

-$738.34M

VRT:

$2.35B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SMMT vs. VRT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMMT
SMMT Risk / Return Rank: 2525
Overall Rank
SMMT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
SMMT Sortino Ratio Rank: 2828
Sortino Ratio Rank
SMMT Omega Ratio Rank: 2828
Omega Ratio Rank
SMMT Calmar Ratio Rank: 2121
Calmar Ratio Rank
SMMT Martin Ratio Rank: 2424
Martin Ratio Rank

VRT
VRT Risk / Return Rank: 9393
Overall Rank
VRT Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
VRT Sortino Ratio Rank: 9191
Sortino Ratio Rank
VRT Omega Ratio Rank: 9090
Omega Ratio Rank
VRT Calmar Ratio Rank: 9595
Calmar Ratio Rank
VRT Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMMT vs. VRT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and Vertiv Holdings Co. (VRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SMMTVRTDifference
Sharpe ratioReturn per unit of total volatility

-3.21

Sortino ratioReturn per unit of downside risk

-3.45

Omega ratioGain probability vs. loss probability

0.98

1.41

-0.43

Calmar ratioReturn relative to maximum drawdown

-0.60

6.53

-7.13

Martin ratioReturn relative to average drawdown

-0.92

18.20

-19.12

SMMT vs. VRT - Sharpe Ratio Comparison

The current SMMT Sharpe Ratio is -0.42, which is lower than the VRT Sharpe Ratio of 2.79. The chart below compares the historical Sharpe Ratios of SMMT and VRT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SMMTVRTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.42

2.79

-3.21

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.08

1.03

-0.95

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

0.02

1.00

-0.98

Drawdowns

SMMT vs. VRT - Drawdown Comparison

The maximum SMMT drawdown since its inception was -95.75%, which is greater than VRT's maximum drawdown of -71.24%. Use the drawdown chart below to compare losses from any high point for SMMT and VRT.


Loading charts...

Drawdown Indicators


SMMTVRTDifference

Max Drawdown

Largest peak-to-trough decline

-95.75%

-71.24%

-24.51%

Max Drawdown (1Y)

Largest decline over 1 year

-52.76%

-24.78%

-27.98%

Max Drawdown (3Y)

Largest decline over 3 years

-62.26%

-61.28%

-0.98%

Max Drawdown (5Y)

Largest decline over 5 years

-91.78%

-71.24%

-20.54%

Max Drawdown (10Y)

Largest decline over 10 years

-95.75%

Current Drawdown

Current decline from peak

-61.55%

-20.11%

-41.44%

Average Drawdown

Average peak-to-trough decline

-57.64%

-16.22%

-41.42%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.32%

8.89%

+25.43%

Volatility

SMMT vs. VRT - Volatility Comparison

Summit Therapeutics Inc. (SMMT) has a higher volatility of 22.47% compared to Vertiv Holdings Co. (VRT) at 16.60%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than VRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SMMTVRTDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.47%

16.60%

+5.87%

Volatility (6M)

Calculated over the trailing 6-month period

56.53%

45.55%

+10.98%

Volatility (1Y)

Calculated over the trailing 1-year period

75.95%

58.11%

+17.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

185.12%

61.81%

+123.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

144.63%

54.61%

+90.02%

Dividends

SMMT vs. VRT - Dividend Comparison

SMMT has not paid dividends to shareholders, while VRT's dividend yield for the trailing twelve months is around 0.07%.


PositionTTM202520242023202220212020
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VRT
Vertiv Holdings Co.
0.07%0.11%0.10%0.05%0.07%0.04%0.05%

Financials

SMMT vs. VRT - Financials Comparison

This section allows you to compare key financial metrics between Summit Therapeutics Inc. and Vertiv Holdings Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-500.00M0.00500.00M1.00B1.50B2.00B2.50B3.00B202220232024202520260
2.65B
(SMMT) Total Revenue
(VRT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SMMT and VRT have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMMT has higher volatility (22.47%) compared to VRT (16.60%). In terms of maximum drawdown, SMMT dropped -95.75% vs VRT's -71.24%.

VRT currently has the higher Sharpe Ratio (2.79 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SMMT and VRT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer